Related Experiment Video
Updated: Jun 16, 2026

A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium
LiYong Chen1, FuRong Wang, XiangLan Sun
1Shandong Provincial Hospital Affiliated to Shandong University, Shandong 250021, China.
Abstract:
Chronic and heavy alcohol consumption is one of the causes of heart diseases. However, the effects of ethanol on insulin sensitivity in myocardium has been unclear. To investigate the effects of ethanol on the expression of AMP-activated protein kinase (AMPK), myocyte enhancer factor 2 (MEF2) and glucose transporter 4 (GLUT4), all of which are involved in the regulation of insulin sensitivity, in the myocardium, we performed three parts of experiments in vivo and in vitro. I: Rats were injected with 5-amino-4-imidazolecarboxamide ribonucleotide (AICAR, 0.8 mg.kg(-l)) for 2 h. II: Rats received different dose (0.5, 2.5 or 5 g.kg(-l).d(-l)) of ethanol for 22-week. III: Primary neonatal rat cardiomyocytes were isolated and treated with or without 100 mM ethanol or 1 mM AICAR for 4 h. The cardiac protein and mRNA expression of AMPKalpha subunits, MEF2 and GLUT4 were observed by western-blotting and RT-PCR, respectively. Serum TNFalpha levels were assessed by ELISA. The results showed chronic ethanol exposure induced insulin resistance. Ethanol decreased the mRNA levels of AMPKalpha1 and alpha2, the protein levels of total- and phospho-AMPKalpha in cardiomyocytes. Similarly, ethanol showed inhibitory effects on both the mRNA and protein levels of MEF2A and 2D, and GLUT4 in a dose-response-like fashion. Correlation analysis implied an association between phospho-AMPKalpha and MEF2A or MEF2D, and between the levels of MEF2 protein and GLUT4 transcription. In addition, ethanol elevated serum TNFalpha level. Taken together, chronic ethanol exposure decreases the expression of AMPKalpha and MEF2, and is associated with GLUT4 decline in rat myocardium.
Insights
Chronic alcohol consumption impairs heart insulin sensitivity by reducing AMP-activated protein kinase (AMPK) and myocyte enhancer factor 2 (MEF2) expression, leading to decreased glucose transporter 4 (GLUT4) levels.
Area of Science:
- Cardiovascular Science
- Metabolic Research
- Toxicology
Background:
- Chronic and heavy alcohol consumption is a known risk factor for heart disease.
- The specific impact of ethanol on myocardial insulin sensitivity remains incompletely understood.
Purpose of the Study:
- To investigate the effects of ethanol on the expression of key regulators of insulin sensitivity in the myocardium: AMP-activated protein kinase (AMPK), myocyte enhancer factor 2 (MEF2), and glucose transporter 4 (GLUT4).
Main Methods:
- In vivo studies involving rats treated with ethanol or AICAR.
- In vitro experiments using primary neonatal rat cardiomyocytes exposed to ethanol or AICAR.
- Analysis of cardiac protein and mRNA expression (AMPK, MEF2, GLUT4) via Western blotting and RT-PCR.
- Assessment of serum TNF-alpha levels using ELISA.
Main Results:
- Chronic ethanol exposure induced insulin resistance in the myocardium.
- Ethanol significantly decreased mRNA and protein levels of AMPKalpha subunits and MEF2 (isoforms A and D) in a dose-dependent manner.
- Ethanol inhibited GLUT4 expression, with correlations observed between phospho-AMPKalpha and MEF2, and between MEF2 and GLUT4.
- Elevated serum TNF-alpha levels were noted following ethanol exposure.
Conclusions:
- Chronic ethanol consumption negatively impacts myocardial insulin sensitivity.
- Ethanol reduces the expression of AMPKalpha and MEF2, which is associated with a decline in GLUT4 levels in the rat myocardium.
- These molecular changes likely contribute to alcohol-induced heart dysfunction and insulin resistance.
More Related Videos
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025